Invesco Ltd. Quidel Ortho Corp Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Quidel Ortho Corp stock. As of the latest transaction made, Invesco Ltd. holds 2,008,153 shares of QDEL stock, worth $78.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

2,008,153

Previous 303,059 562.63%

Holding current value

$78.2 Million

Previous $10.1 Million 809.42%

% of portfolio

0.02%

Previous 0.0%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$29.96 - $46.4 $51.1 Million - $79.1 Million	1,705,094 Added 562.63%	2,008,153 $91.6 Million
Q2 2024 Aug 13, 2024	SELL	$32.9 - $47.0 $447,736 - $639,623	-13,609 Reduced 4.3%	303,059 $10.1 Million
Q1 2024 May 14, 2024	SELL	$41.76 - $74.73 $778,448 - $1.39 Million	-18,641 Reduced 5.56%	316,668 $15.2 Million
Q4 2023 Feb 12, 2024	BUY	$58.16 - $75.44 $1.48 Million - $1.92 Million	25,388 Added 8.19%	335,309 $24.7 Million
Q3 2023 Nov 13, 2023	SELL	$70.9 - $88.63 $554,154 - $692,732	-7,816 Reduced 2.46%	309,921 $22.6 Million
Q2 2023 Aug 11, 2023	SELL	$81.09 - $94.16 $605,336 - $702,904	-7,465 Reduced 2.3%	317,737 $26.3 Million
Q1 2023 May 12, 2023	SELL	$82.98 - $91.46 $6.56 Million - $7.23 Million	-79,006 Reduced 19.55%	325,202 $29 Million
Q4 2022 Feb 13, 2023	BUY	$66.93 - $97.5 $119,068 - $173,452	1,779 Added 0.44%	404,208 $34.6 Million
Q3 2022 Nov 14, 2022	SELL	$69.86 - $107.63 $1.19 Million - $1.83 Million	-17,036 Reduced 4.06%	402,429 $28.8 Million
Q2 2022 Aug 15, 2022	BUY	$89.06 - $117.64 $37.4 Million - $49.3 Million	419,465 New	419,465 $40.8 Million

Others Institutions Holding QDEL

# of Institutions

293

Shares Held

68.1M

Call Options Held

310K

Put Options Held

134K

View Full List

About QuidelOrtho Corp

Ticker QDEL
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 66,952,900
Market Cap $2.61B
Description
QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tes...

More about QDEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account